A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection

Author:

Humphrey Rachel W.,Wyvill Kathleen M.,Nguyen Bach-Yen,Shay Laura E.,Kohler David R.,Steinberg Seth M.,Ueno Takamasa,Fukasawa Tominaga,Shintani Makoto,Hayashi Hideya,Mitsuya Hiroaki,Yarchoan Robert

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference36 articles.

1. WHO case definitions for AIDS surveillance in adults and adolescents. Update: trends in AIDS diagnosis and reporting under the expanded surveillance definition for adolescents and adults—United States, 1993;Wkly Epidemiol. Rec.,1994

2. Pathogenesis of HIV-1-protease inhibitor- associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance;Carr;Lancet,1998

3. In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddI;Chokekijchai;Antiviral Res.,1995

4. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors;Condra;Nature,1995

5. Condra, J.H., Holder, D.J., Schleif, W.A. et al., 1996. Bi-directional inhibition of HIV-1 drug resistance selection by combination therapy with indinavir and reverse transcriptase inhibitors. XI International Conference on AIDS, Vancouver, July 7–12, 1996. Supplement.

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3